搜索
诺华制药
NVS添加自选
159.870USD
+5.730+3.72%
收盘 07/02, 13:00（美东）报价延迟15分钟
305.05B总市值
22.75市盈率 TTM
关于 诺华制药 公司
诺华公司为瑞士总部的全球制药巨头，专注创新处方药的研发、制造与行销。公司现以单一 创新药物 部门运营，聚焦免疫、肿瘤、神经、心血管、肾脏及代谢等治疗领域，并运用数字平台加速临床与商业决策。此前属下的仿制药与生物仿制药业务已分拆为独立公司 Sandoz，因此诺华资源得以全面投入先进疗法与下一代技术平台。
诺华制药简介
公司代码NVS
公司名称Novartis AG
上市日期May 07, 2001
CEONarasimhan (Vasant)
员工数量75883
证券类型Depository Receipt
年结日May 07
公司地址Lichtstrasse 35
城市BASEL
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Switzerland
邮编4056
电话41613241111
网址https://www.novartis.com/
公司代码NVS
上市日期May 07, 2001
CEONarasimhan (Vasant)
诺华制药公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
Mr. Frans van Houten
Mr. Frans van Houten
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Steffen Lang, Ph.D.
Dr. Steffen Lang, Ph.D.
President - Operations, Member of the Executive Committee
President - Operations, Member of the Executive Committee
--
--
Mr. Patrice Bula
Mr. Patrice Bula
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
常见问题
诺华制药的前五大股东是谁？
诺华制药 的前五大股东如下：Mr. Harry Kirsch
有多少机构持有诺华制药(NVS)的股份？
截至2026Q1，共有2164家机构持有诺华制药的股份，合计持有的股份价值约为143.01M，占公司总股份的7.49%。与2025Q4相比，机构持股有所增加，增幅为-1630148.00。
哪个业务部门对诺华制药的收入贡献最大？
在2026Q1，Rest of portfolio业务部门对诺华制药的收入贡献最大，创收10.02B，占总收入的18.37%。